Sperm Capacitation Assay as a Tool to Predict Sperm Potential to Fertilize in IVF Treatment
NCT ID: NCT00731159
Last Updated: 2008-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2008-07-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Sperm capacitation:
Sperm capacitation is measured in a sample of the same ejaculated sperm unit given for fertilizing human oocytes in an IVF treatment cycle
sperm capacitation
sperm capacitation measured at Bar Ilan University
biologic
sperm synthesis of G-actine to F-actine
sperm capacitation
sperm synthesis of G-actine to F-actine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sperm capacitation
sperm capacitation measured at Bar Ilan University
biologic
sperm synthesis of G-actine to F-actine
sperm capacitation
sperm synthesis of G-actine to F-actine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normo-responding woman
* non ICSI cycles
Exclusion Criteria
* Low responders-less than 8 oocytes
* Male patients with low semen volume
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assaf-Harofeh Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Assaf Harofeh MC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assaf Harofeh MC
Beer Yaacov, Zerifin, Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
arieh raziel, prof
Role: primary
raphael ron-el, prof
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
54/08
Identifier Type: -
Identifier Source: org_study_id